Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Oral lichen planus and apremilast: Case series and literature review.
Journal: JAAD case reports
Published: August 08, 2026
Disseminated coccidioidomycosis masquerading as bacterial cellulitis.
Journal: Cleveland Clinic journal of medicine
Published: June 01, 2026
Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.
Journal: Nature medicine
Published: May 28, 2026
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel.
Journal: Journal of drugs in dermatology : JDD
Published: May 04, 2026
Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
Journal: JAMA dermatology
Published: March 18, 2026
Pyoderma gangrenosum with complications of severe trigeminal neuralgia.
Journal: JAAD case reports
Published: July 29, 2025
Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.
Journal: Dermatology and therapy
Published: July 25, 2025
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.
Journal: Dermatology and therapy
Published: June 20, 2025
Drug-Induced Leukocytoclastic Vasculitis From an Unreported Source: Daptomycin.
Journal: Cureus
Published: April 17, 2025
Drug Reaction With Eosinophilia and Systemic Symptoms and Severe Drug-Induced Liver Injury After Off-Label Zonisamide Use for Weight Loss.
Journal: ACG case reports journal
Published: December 06, 2024
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study.
Journal: Journal of the American Academy of Dermatology
Published: June 10, 2024
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
Journal: Nature medicine
Published: July 21, 2023
Last Updated: 09/26/2026